Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Idiopathic Dyspepsia.

Vincenzo Stanghellini1, Elisabetta Poluzzi, Fabrizio De Ponti

  • 1Department of Internal Medicine and Gastroenterology, University of Bologna, Policlinico S. Orsola-Malpighi Via Massarenti 9, Bologna, I-40138, Italy. v.stanghellini@unibo.it.

Current Treatment Options in Gastroenterology
|March 17, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Major Adverse Cardiac Events with Ondansetron: The Role of Observational Evidence to Inform Actionable Safer Prescribing in Cardio-Oncology.

Clinical pharmacology and therapeutics·2026
Same author

Learning planetary health through international & interprofessional education: a qualitative study of student reflections.

Medical education online·2026
Same author

Healthcare professionals' perspectives on medication adherence-supporting tools: a cross‑sectional survey in Italy.

European journal of clinical pharmacology·2026
Same author

Integrating Planetary Health in Health Guidelines (GRADE Guidance 46).

Annals of internal medicine·2026
Same author

Posterior Reversible Encephalopathy Syndrome with Angiogenesis Inhibitors for Solid Tumours: Clues from a Disproportionality Analysis of the FDA Adverse Event Reporting System and Pharmacodynamics.

Targeted oncology·2026
Same author

The Contribution to the Assignment of Defined Daily Dose (DDD) to Antineoplastic Drugs of the Italian Working Group on DDD.

Pharmacoepidemiology and drug safety·2026
Same journal

Esophageal Disorders in the Older Adult.

Current treatment options in gastroenterology·2025
Same journal

Endobariatrics: a Still Underutilized Weight Loss Tool.

Current treatment options in gastroenterology·2023
Same journal

Management of Post Ablative Barrett's Esophagus: a Review of Current Practices and Look at Emerging Technologies.

Current treatment options in gastroenterology·2023
Same journal

Inflammatory Bowel Disease Therapy and Venous Thromboembolism.

Current treatment options in gastroenterology·2023
Same journal

Ileal Pouch-Anal Anastomosis in the Older Adult: a Review of Postoperative Outcomes and Pouchitis Treatment.

Current treatment options in gastroenterology·2023
Same journal

Celiac Disease in the Elderly.

Current treatment options in gastroenterology·2023
See all related articles

Idiopathic dyspepsia, characterized by upper abdominal discomfort, requires individualized treatment based on symptoms. Proton pump inhibitors for pain or prokinetics for non-pain symptoms are initial options.

Area of Science:

  • Gastroenterology
  • Internal Medicine

Background:

  • Idiopathic dyspepsia presents as epigastric pain or discomfort without identifiable organic causes.
  • Symptoms can overlap with gastroesophageal reflux disease (GERD) and irritable bowel syndrome (IBS).
  • Potential contributing factors include gastrointestinal motility disorders, hypersensitivity, and psychosocial influences.

Purpose of the Study:

  • To review current understanding and treatment strategies for idiopathic dyspepsia.
  • To guide clinicians in selecting appropriate therapies based on predominant symptoms.

Main Methods:

  • Literature review of studies on idiopathic dyspepsia.
  • Analysis of treatment efficacy for various drug classes and therapeutic approaches.

Main Results:

Related Experiment Videos

  • Helicobacter pylori eradication offers limited symptom improvement.
  • Proton pump inhibitors (PPIs) show benefit, particularly in patients with non-erosive GERD.
  • Prokinetic agents may help with non-painful dyspeptic symptoms like fullness and nausea.

Conclusions:

  • Treatment for idiopathic dyspepsia should be tailored to individual symptom presentation.
  • Initial therapy may involve PPIs for pain/burning or prokinetics for fullness/nausea.
  • Combination therapies, visceral analgesics, antidepressants, and psychological interventions may be considered for non-responders.